Video: New Biological Therapy Ilaris(R) Approved in US to Treat Children and Adults with CAPS, a Serious Life-Long Auto-Inflammato...(r for any additional indication. Nor can...),Health

Date:6/18/2009

r for any additional indication. Nor can there be any guarantee that Ilaris will achieve any levels of revenue in the future. In particular, management's expectations regarding Ilaris could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, preventive vaccines, diagnostic tools, cost-saving generic pharmaceuticals and consumer health products. Novartis is the only company with leading positions in these areas. In 2008, the Group's continuing operations achieved net sales of USD 41.5 billion an
'/>"/>

SOURCE Novartis Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Video: BeautyScoop(R) Is a Trip to Your Nutritionist and Dermatologist in One Single Packet. Lauren Slayton, NYC Nutritionist & Owner of FoodTrainers
2. VIDEO: Perot Systems Launches Xcelys(TM) for Revenue Cycle Management
3. Video: CVS/pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide
4. Video: Bon Secours Finds Young Families are In Line With National Economic Trend
5. Video: Plan for Long Term Care Before the Crisis Hits
6. Video: truth(R) Asks: Do You Have What it Takes?
7. Video: NSF Enlists Renowned Womens Health Expert to School America on Sleeping Smart
8. Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males
9. Video: GoGirl!, Dont Take Life Sitting Down
10. Video: CVS/pharmacy and National Council on Aging Help Seniors Get the Cost-Saving Benefits they Need
11. Video: AccuVein Launches First Portable, Non-Contact Vein Illumination Device